In a recent study posted to the bioRxiv* preprint server, researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike (S) proteins of several severe ...
Current vaccines have greatly diminished the severity of the COVID-19 pandemic, even though they do not entirely prevent infection and transmission, likely due to insufficient immunity in the upper ...
In a recent study published in the journal PNAS, researchers demonstrated higher comparative efficacy of the intranasal (IN) route of coronavirus disease 2019 (COVID-19) vaccine administration versus ...
Simple pharmaceutical interventions could help older brains cope with memory impairment and recovery after surgery, new ...
A Yale University study on delivering mRNA through intranasal vaccination in mice does not show and did not test the possibility of using the technology to vaccinate people without their consent, as ...
Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice. The researchers believe this is the first ...
A novel intranasal antibody treatment shows potential in fighting tau protein buildup, which is a key factor in neurodegenerative diseases such as Alzheimer’s. A single dose of this treatment in aged ...
New research led by a team from Cornell University and the University of British Columbia has demonstrated a novel nasal spray can prevent infection from SARS-CoV-2. The experimental treatment was ...
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback